Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1986 Dec;78(6):1504–1512. doi: 10.1172/JCI112742

Radioimmunoassay of growth hormone-dependent insulinlike growth factor binding protein in human plasma.

R C Baxter, J L Martin
PMCID: PMC423906  PMID: 2431001

Abstract

A specific radioimmunoassay has been established for a growth hormone-dependent insulinlike growth factor (IGF) binding protein (BP) from human plasma. Although the assay was directed against a 53-kD, acid-stable BP subunit, the main immunoreactive BP in the circulation had an apparent molecular mass of approximately 125 kD. Only higher primate species showed cross-reactivity, and IGF-I, IGF-II, and other peptides were without effect. Circulating BP levels in healthy subjects rose threefold from early childhood to puberty. In 65 adults aged 18 to 65, the mean level (+/- SD) was 6.12 +/- 1.43 micrograms/ml, and declined with age. Strong growth hormone-dependence of BP was also seen; there was a 2.2-fold increase in active acromegaly and a 50-80% reduction in growth hormone deficiency. Poorly controlled diabetic subjects had BP levels 40% below normal, whereas in renal failure and third-term pregnancy a mild elevation was seen. Measurement of BP may provide a useful adjunct to IGF assays in growth disorders.

Full text

PDF
1504

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bala R. M., Bhaumick B. Radioimmunoassay of a basic somatomedin: comparison of various assay techniques and somatomedin levels in various sera. J Clin Endocrinol Metab. 1979 Nov;49(5):770–777. doi: 10.1210/jcem-49-5-770. [DOI] [PubMed] [Google Scholar]
  2. Baxter R. C., Brown A. S., Turtle J. R. Radioimmunoassay for somatomedin C: comparison with radioreceptor assay in patients with growth-hormone disorders, hypothyroidism, and renal failure. Clin Chem. 1982 Mar;28(3):488–495. [PubMed] [Google Scholar]
  3. Baxter R. C., Martin J. L., Tyler M. I., Howden M. E. Growth hormone-dependent insulin-like growth factor (IGF) binding protein from human plasma differs from other human IGF binding proteins. Biochem Biophys Res Commun. 1986 Sep 30;139(3):1256–1261. doi: 10.1016/s0006-291x(86)80313-8. [DOI] [PubMed] [Google Scholar]
  4. Baxter R. C. The somatomedins: insulin-like growth factors. Adv Clin Chem. 1986;25:49–115. doi: 10.1016/s0065-2423(08)60124-9. [DOI] [PubMed] [Google Scholar]
  5. Baxter R. C., de Mellow J. S. Measurement of insulin-like growth factor-II by radioreceptor assay using ovine placental membranes. Clin Endocrinol (Oxf) 1986 Mar;24(3):267–278. doi: 10.1111/j.1365-2265.1986.tb03267.x. [DOI] [PubMed] [Google Scholar]
  6. Binoux M., Seurin D., Lassarre C., Gourmelen M. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels. J Clin Endocrinol Metab. 1984 Sep;59(3):453–462. doi: 10.1210/jcem-59-3-453. [DOI] [PubMed] [Google Scholar]
  7. Cohen K. L., Nissley S. P. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol (Copenh) 1976 Oct;83(2):243–258. doi: 10.1530/acta.0.0830243. [DOI] [PubMed] [Google Scholar]
  8. Copeland K. C., Underwood L. E., Van Wyk J. J. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles. J Clin Endocrinol Metab. 1980 Apr;50(4):690–697. doi: 10.1210/jcem-50-4-690. [DOI] [PubMed] [Google Scholar]
  9. D'Ercole A. J., Drop S. L., Kortleve D. J. Somatomedin-C/insulin-like growth factor I-binding proteins in human amniotic fluid and in fetal and postnatal blood: evidence of immunological homology. J Clin Endocrinol Metab. 1985 Oct;61(4):612–617. doi: 10.1210/jcem-61-4-612. [DOI] [PubMed] [Google Scholar]
  10. Daughaday W. H., Mariz I. K., Blethen S. L. Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol-extracted serum. J Clin Endocrinol Metab. 1980 Oct;51(4):781–788. doi: 10.1210/jcem-51-4-781. [DOI] [PubMed] [Google Scholar]
  11. Daughaday W. H., Ward A. P., Goldberg A. C., Trivedi B., Kapadia M. Characterization of somatomedin binding in human serum by ultracentrifugation and gel filtration. J Clin Endocrinol Metab. 1982 Nov;55(5):916–921. doi: 10.1210/jcem-55-5-916. [DOI] [PubMed] [Google Scholar]
  12. Drop S. L., Kortleve D. J., Guyda H. J. Isolation of a somatomedin-binding protein from preterm amniotic fluid. Development of a radioimmunoassay. J Clin Endocrinol Metab. 1984 Nov;59(5):899–907. doi: 10.1210/jcem-59-5-899. [DOI] [PubMed] [Google Scholar]
  13. Drop S. L., Kortleve D. J., Guyda H. J., Posner B. I. Immunoassay of a somatomedin-binding protein from human amniotic fluid: levels in fetal, neonatal, and adult sera. J Clin Endocrinol Metab. 1984 Nov;59(5):908–915. doi: 10.1210/jcem-59-5-908. [DOI] [PubMed] [Google Scholar]
  14. Enberg G. Purification of a high molecular weight somatomedin binding protein from human plasma. Biochem Biophys Res Commun. 1986 Feb 26;135(1):178–182. doi: 10.1016/0006-291x(86)90959-9. [DOI] [PubMed] [Google Scholar]
  15. Furlanetto R. W. The somatomedin C binding protein: evidence for a heterologous subunit structure. J Clin Endocrinol Metab. 1980 Jul;51(1):12–19. doi: 10.1210/jcem-51-1-12. [DOI] [PubMed] [Google Scholar]
  16. Furlanetto R. W., Underwood L. E., Van Wyk J. J., D'Ercole A. J. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J Clin Invest. 1977 Sep;60(3):648–657. doi: 10.1172/JCI108816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goldberg A. C., Trivedi B., Delmez J. A., Harter H. R., Daughaday W. H. Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding. J Clin Endocrinol Metab. 1982 Dec;55(6):1040–1045. doi: 10.1210/jcem-55-6-1040. [DOI] [PubMed] [Google Scholar]
  18. Hall K., Brandt J., Enberg G., Fryklund L. Immunoreactive somatomedin A in human serum. J Clin Endocrinol Metab. 1979 Feb;48(2):271–278. doi: 10.1210/jcem-48-2-271. [DOI] [PubMed] [Google Scholar]
  19. Hall K., Enberg G., Hellem E., Lundin G., Ottosson-Seeberger A., Sara V., Trygstad O., Ofverholm U. Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients with growth hormone deficiency. J Clin Endocrinol Metab. 1984 Oct;59(4):587–594. doi: 10.1210/jcem-59-4-587. [DOI] [PubMed] [Google Scholar]
  20. Hintz R. L., Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab. 1977 Nov;45(5):988–995. doi: 10.1210/jcem-45-5-988. [DOI] [PubMed] [Google Scholar]
  21. Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 1981 Jul;53(1):100–104. doi: 10.1210/jcem-53-1-100. [DOI] [PubMed] [Google Scholar]
  22. Kaufmann U., Zapf J., Torretti B., Froesch E. R. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. J Clin Endocrinol Metab. 1977 Jan;44(1):160–166. doi: 10.1210/jcem-44-1-160. [DOI] [PubMed] [Google Scholar]
  23. Kuffer A. D., Herington A. C. Partial purification of a specific inhibitor of the insulin-like growth factors by reversed-phase high-performance liquid chromatography. J Chromatogr. 1984 Dec 7;336(1):87–92. doi: 10.1016/s0378-4347(00)85132-4. [DOI] [PubMed] [Google Scholar]
  24. Martin J. L., Baxter R. C. Antibody against acid-stable insulin-like growth factor binding protein detects 150,000 mol wt growth hormone-dependent complex in human plasma. J Clin Endocrinol Metab. 1985 Oct;61(4):799–801. doi: 10.1210/jcem-61-4-799. [DOI] [PubMed] [Google Scholar]
  25. Martin J. L., Baxter R. C. Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem. 1986 Jul 5;261(19):8754–8760. [PubMed] [Google Scholar]
  26. Merimee T. J., Zapf J., Froesch E. R. Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf. J Clin Endocrinol Metab. 1982 Jun;54(6):1101–1103. doi: 10.1210/jcem-54-6-1101. [DOI] [PubMed] [Google Scholar]
  27. Morris D. H., Schalch D. S. Structure of somatomedin-binding protein: alkaline pH-induced dissociation of an acid-stable, 60,000 molecular weight complex into smaller components. Endocrinology. 1982 Sep;111(3):801–805. doi: 10.1210/endo-111-3-801. [DOI] [PubMed] [Google Scholar]
  28. Ooi G. T., Herington A. C. Covalent cross-linking of insulin-like growth factor-1 to a specific inhibitor from human serum. Biochem Biophys Res Commun. 1986 May 29;137(1):411–417. doi: 10.1016/0006-291x(86)91225-8. [DOI] [PubMed] [Google Scholar]
  29. Póvoa G., Enberg G., Jörnvall H., Hall K. Isolation and characterization of a somatomedin-binding protein from mid-term human amniotic fluid. Eur J Biochem. 1984 Oct 15;144(2):199–204. doi: 10.1111/j.1432-1033.1984.tb08449.x. [DOI] [PubMed] [Google Scholar]
  30. Póvoa G., Roovete A., Hall K. Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 1984 Dec;107(4):563–570. doi: 10.1530/acta.0.1070563. [DOI] [PubMed] [Google Scholar]
  31. Rieu M., Binoux M. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase. J Clin Endocrinol Metab. 1985 Apr;60(4):781–785. doi: 10.1210/jcem-60-4-781. [DOI] [PubMed] [Google Scholar]
  32. Schalch D. S., Tollefsen S. E., Klingensmith G. J., Gotlin R. W., Diehl M. J. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency. J Clin Endocrinol Metab. 1982 Jul;55(1):49–55. doi: 10.1210/jcem-55-1-49. [DOI] [PubMed] [Google Scholar]
  33. Scott C. D., Martin J. L., Baxter R. C. Production of insulin-like growth factor I and its binding protein by adult rat hepatocytes in primary culture. Endocrinology. 1985 Mar;116(3):1094–1101. doi: 10.1210/endo-116-3-1094. [DOI] [PubMed] [Google Scholar]
  34. White R. M., Nissley S. P., Moses A. C., Rechler M. M., Johnsonbaugh R. E. The growth hormone dependence of a somatomedin-binding protein in human serum. J Clin Endocrinol Metab. 1981 Jul;53(1):49–57. doi: 10.1210/jcem-53-1-49. [DOI] [PubMed] [Google Scholar]
  35. Wilkins J. R., D'Ercole A. J. Affinity-labeled plasma somatomedin-C/insulinlike growth factor I binding proteins. Evidence of growth hormone dependence and subunit structure. J Clin Invest. 1985 Apr;75(4):1350–1358. doi: 10.1172/JCI111836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zapf J., Morell B., Walter H., Laron Z., Froesch E. R. Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) 1980 Dec;95(4):505–517. doi: 10.1530/acta.0.0950505. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES